Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.
Company Details
- Employees
- 66
- Founded
- -
- Address
- 180 3rd Ave., Sixth Floor, Waltham,massachusetts 02451,united States
- Phone
- 617.858.0041
- in****@****ktx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- skyhawktx.com
- HQ
- Waltham, Massachusetts
Skyhawk Therapeutics Questions
Skyhawk Therapeutics's helpline number is 617.858.0041
Skyhawk Therapeutics's website is skyhawktx.com
Skyhawk Therapeutics's LinkedIn profile is https://www.linkedin.com/company/skyhawk-therapeutics
Skyhawk Therapeutics has
66 employees.
View email and phone details for 66
employees at Skyhawk Therapeutics.
Skyhawk Therapeutics's industry is
Biotechnology Research
Skyhawk Therapeutics's top competitors are
Dragonfly Therapeutics, Inc.,
Tessera Therapeutics,
Intellia Therapeutics, Inc.,
Entrada Therapeutics,
Arrakis Therapeutics,
Beam Therapeutics,
Jnana Therapeutics,
Kymera Therapeutics,
Sarepta Therapeutics,
Mersana Therapeutics.
Skyhawk Therapeutics's support email address is info@skyhawktx.com
Skyhawk Therapeutics's categories are Biotechnology Research
Skyhawk Therapeutics's founding year is 2016
